4565 fundamentals
An in-depth look to NXERA PHARMA CO LTD operating, investing, and financing activities
4565 free cash flow for Q4 23 is -1.14 B JPY. For 2023, 4565 free cash flow was -6.08 B JPY and operating cash flow was -5.27 B JPY.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: JPY
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM